Global Cell-Based Immunotherapy Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Cell-Based Immunotherapy market size was valued at US$ million in 2023. With growing demand in downstream market, the Cell-Based Immunotherapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Cell-Based Immunotherapy market. Cell-Based Immunotherapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cell-Based Immunotherapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cell-Based Immunotherapy market.
Key Features:
The report on Cell-Based Immunotherapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cell-Based Immunotherapy market. It may include historical data, market segmentation by Type (e.g., Autologous Cellular Immunotherapy, Chimeric Antigen Receptor (CAR) T-Cell Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cell-Based Immunotherapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cell-Based Immunotherapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cell-Based Immunotherapy industry. This include advancements in Cell-Based Immunotherapy technology, Cell-Based Immunotherapy new entrants, Cell-Based Immunotherapy new investment, and other innovations that are shaping the future of Cell-Based Immunotherapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cell-Based Immunotherapy market. It includes factors influencing customer ' purchasing decisions, preferences for Cell-Based Immunotherapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cell-Based Immunotherapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cell-Based Immunotherapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cell-Based Immunotherapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cell-Based Immunotherapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cell-Based Immunotherapy market.
Market Segmentation:
Cell-Based Immunotherapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Cell-Based Immunotherapy market size was valued at US$ million in 2023. With growing demand in downstream market, the Cell-Based Immunotherapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Cell-Based Immunotherapy market. Cell-Based Immunotherapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cell-Based Immunotherapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cell-Based Immunotherapy market.
Key Features:
The report on Cell-Based Immunotherapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cell-Based Immunotherapy market. It may include historical data, market segmentation by Type (e.g., Autologous Cellular Immunotherapy, Chimeric Antigen Receptor (CAR) T-Cell Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cell-Based Immunotherapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cell-Based Immunotherapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cell-Based Immunotherapy industry. This include advancements in Cell-Based Immunotherapy technology, Cell-Based Immunotherapy new entrants, Cell-Based Immunotherapy new investment, and other innovations that are shaping the future of Cell-Based Immunotherapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cell-Based Immunotherapy market. It includes factors influencing customer ' purchasing decisions, preferences for Cell-Based Immunotherapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cell-Based Immunotherapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cell-Based Immunotherapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cell-Based Immunotherapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cell-Based Immunotherapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cell-Based Immunotherapy market.
Market Segmentation:
Cell-Based Immunotherapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Autologous Cellular Immunotherapy
- Chimeric Antigen Receptor (CAR) T-Cell Therapy
- Dendritic Cell-based Vaccine Therapy
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Gilead Sciences
- AbbVie
- Bristol-Myers Squibb
- Amgen
- AstraZeneca
- Biogen
- Boehringer Ingelheim
- Eli Lilly and Company
- GSK
- Pfizer
- Roche
- Takara Bio
- Bausch Health
- Apac Biotech
- Dendreon Pharmaceuticals (SanPower)
- JW CreaGene
- Green Cross Corp
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell-Based Immunotherapy Market Size 2019-2030
2.1.2 Cell-Based Immunotherapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cell-Based Immunotherapy Segment by Type
2.2.1 Autologous Cellular Immunotherapy
2.2.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy
2.2.3 Dendritic Cell-based Vaccine Therapy
2.3 Cell-Based Immunotherapy Market Size by Type
2.3.1 Cell-Based Immunotherapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cell-Based Immunotherapy Market Size Market Share by Type (2019-2024)
2.4 Cell-Based Immunotherapy Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Centers
2.4.4 Others
2.5 Cell-Based Immunotherapy Market Size by Application
2.5.1 Cell-Based Immunotherapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cell-Based Immunotherapy Market Size Market Share by Application (2019-2024)
3 CELL-BASED IMMUNOTHERAPY MARKET SIZE BY PLAYER
3.1 Cell-Based Immunotherapy Market Size Market Share by Players
3.1.1 Global Cell-Based Immunotherapy Revenue by Players (2019-2024)
3.1.2 Global Cell-Based Immunotherapy Revenue Market Share by Players (2019-2024)
3.2 Global Cell-Based Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL-BASED IMMUNOTHERAPY BY REGIONS
4.1 Cell-Based Immunotherapy Market Size by Regions (2019-2024)
4.2 Americas Cell-Based Immunotherapy Market Size Growth (2019-2024)
4.3 APAC Cell-Based Immunotherapy Market Size Growth (2019-2024)
4.4 Europe Cell-Based Immunotherapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Cell-Based Immunotherapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Cell-Based Immunotherapy Market Size by Country (2019-2024)
5.2 Americas Cell-Based Immunotherapy Market Size by Type (2019-2024)
5.3 Americas Cell-Based Immunotherapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell-Based Immunotherapy Market Size by Region (2019-2024)
6.2 APAC Cell-Based Immunotherapy Market Size by Type (2019-2024)
6.3 APAC Cell-Based Immunotherapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell-Based Immunotherapy by Country (2019-2024)
7.2 Europe Cell-Based Immunotherapy Market Size by Type (2019-2024)
7.3 Europe Cell-Based Immunotherapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell-Based Immunotherapy by Region (2019-2024)
8.2 Middle East & Africa Cell-Based Immunotherapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Cell-Based Immunotherapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL-BASED IMMUNOTHERAPY MARKET FORECAST
10.1 Global Cell-Based Immunotherapy Forecast by Regions (2025-2030)
10.1.1 Global Cell-Based Immunotherapy Forecast by Regions (2025-2030)
10.1.2 Americas Cell-Based Immunotherapy Forecast
10.1.3 APAC Cell-Based Immunotherapy Forecast
10.1.4 Europe Cell-Based Immunotherapy Forecast
10.1.5 Middle East & Africa Cell-Based Immunotherapy Forecast
10.2 Americas Cell-Based Immunotherapy Forecast by Country (2025-2030)
10.2.1 United States Cell-Based Immunotherapy Market Forecast
10.2.2 Canada Cell-Based Immunotherapy Market Forecast
10.2.3 Mexico Cell-Based Immunotherapy Market Forecast
10.2.4 Brazil Cell-Based Immunotherapy Market Forecast
10.3 APAC Cell-Based Immunotherapy Forecast by Region (2025-2030)
10.3.1 China Cell-Based Immunotherapy Market Forecast
10.3.2 Japan Cell-Based Immunotherapy Market Forecast
10.3.3 Korea Cell-Based Immunotherapy Market Forecast
10.3.4 Southeast Asia Cell-Based Immunotherapy Market Forecast
10.3.5 India Cell-Based Immunotherapy Market Forecast
10.3.6 Australia Cell-Based Immunotherapy Market Forecast
10.4 Europe Cell-Based Immunotherapy Forecast by Country (2025-2030)
10.4.1 Germany Cell-Based Immunotherapy Market Forecast
10.4.2 France Cell-Based Immunotherapy Market Forecast
10.4.3 UK Cell-Based Immunotherapy Market Forecast
10.4.4 Italy Cell-Based Immunotherapy Market Forecast
10.4.5 Russia Cell-Based Immunotherapy Market Forecast
10.5 Middle East & Africa Cell-Based Immunotherapy Forecast by Region (2025-2030)
10.5.1 Egypt Cell-Based Immunotherapy Market Forecast
10.5.2 South Africa Cell-Based Immunotherapy Market Forecast
10.5.3 Israel Cell-Based Immunotherapy Market Forecast
10.5.4 Turkey Cell-Based Immunotherapy Market Forecast
10.5.5 GCC Countries Cell-Based Immunotherapy Market Forecast
10.6 Global Cell-Based Immunotherapy Forecast by Type (2025-2030)
10.7 Global Cell-Based Immunotherapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Cell-Based Immunotherapy Product Offered
11.1.3 Novartis Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences Cell-Based Immunotherapy Product Offered
11.2.3 Gilead Sciences Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Cell-Based Immunotherapy Product Offered
11.3.3 AbbVie Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Cell-Based Immunotherapy Product Offered
11.4.3 Bristol-Myers Squibb Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Amgen
11.5.1 Amgen Company Information
11.5.2 Amgen Cell-Based Immunotherapy Product Offered
11.5.3 Amgen Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Amgen Main Business Overview
11.5.5 Amgen Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Cell-Based Immunotherapy Product Offered
11.6.3 AstraZeneca Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Biogen
11.7.1 Biogen Company Information
11.7.2 Biogen Cell-Based Immunotherapy Product Offered
11.7.3 Biogen Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Biogen Main Business Overview
11.7.5 Biogen Latest Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Information
11.8.2 Boehringer Ingelheim Cell-Based Immunotherapy Product Offered
11.8.3 Boehringer Ingelheim Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Boehringer Ingelheim Main Business Overview
11.8.5 Boehringer Ingelheim Latest Developments
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Information
11.9.2 Eli Lilly and Company Cell-Based Immunotherapy Product Offered
11.9.3 Eli Lilly and Company Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Eli Lilly and Company Main Business Overview
11.9.5 Eli Lilly and Company Latest Developments
11.10 GSK
11.10.1 GSK Company Information
11.10.2 GSK Cell-Based Immunotherapy Product Offered
11.10.3 GSK Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 GSK Main Business Overview
11.10.5 GSK Latest Developments
11.11 Pfizer
11.11.1 Pfizer Company Information
11.11.2 Pfizer Cell-Based Immunotherapy Product Offered
11.11.3 Pfizer Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Pfizer Main Business Overview
11.11.5 Pfizer Latest Developments
11.12 Roche
11.12.1 Roche Company Information
11.12.2 Roche Cell-Based Immunotherapy Product Offered
11.12.3 Roche Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Roche Main Business Overview
11.12.5 Roche Latest Developments
11.13 Takara Bio
11.13.1 Takara Bio Company Information
11.13.2 Takara Bio Cell-Based Immunotherapy Product Offered
11.13.3 Takara Bio Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Takara Bio Main Business Overview
11.13.5 Takara Bio Latest Developments
11.14 Bausch Health
11.14.1 Bausch Health Company Information
11.14.2 Bausch Health Cell-Based Immunotherapy Product Offered
11.14.3 Bausch Health Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Bausch Health Main Business Overview
11.14.5 Bausch Health Latest Developments
11.15 Apac Biotech
11.15.1 Apac Biotech Company Information
11.15.2 Apac Biotech Cell-Based Immunotherapy Product Offered
11.15.3 Apac Biotech Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Apac Biotech Main Business Overview
11.15.5 Apac Biotech Latest Developments
11.16 Dendreon Pharmaceuticals (SanPower)
11.16.1 Dendreon Pharmaceuticals (SanPower) Company Information
11.16.2 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product Offered
11.16.3 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Dendreon Pharmaceuticals (SanPower) Main Business Overview
11.16.5 Dendreon Pharmaceuticals (SanPower) Latest Developments
11.17 JW CreaGene
11.17.1 JW CreaGene Company Information
11.17.2 JW CreaGene Cell-Based Immunotherapy Product Offered
11.17.3 JW CreaGene Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 JW CreaGene Main Business Overview
11.17.5 JW CreaGene Latest Developments
11.18 Green Cross Corp
11.18.1 Green Cross Corp Company Information
11.18.2 Green Cross Corp Cell-Based Immunotherapy Product Offered
11.18.3 Green Cross Corp Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Green Cross Corp Main Business Overview
11.18.5 Green Cross Corp Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell-Based Immunotherapy Market Size 2019-2030
2.1.2 Cell-Based Immunotherapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Cell-Based Immunotherapy Segment by Type
2.2.1 Autologous Cellular Immunotherapy
2.2.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy
2.2.3 Dendritic Cell-based Vaccine Therapy
2.3 Cell-Based Immunotherapy Market Size by Type
2.3.1 Cell-Based Immunotherapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Cell-Based Immunotherapy Market Size Market Share by Type (2019-2024)
2.4 Cell-Based Immunotherapy Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Centers
2.4.4 Others
2.5 Cell-Based Immunotherapy Market Size by Application
2.5.1 Cell-Based Immunotherapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Cell-Based Immunotherapy Market Size Market Share by Application (2019-2024)
3 CELL-BASED IMMUNOTHERAPY MARKET SIZE BY PLAYER
3.1 Cell-Based Immunotherapy Market Size Market Share by Players
3.1.1 Global Cell-Based Immunotherapy Revenue by Players (2019-2024)
3.1.2 Global Cell-Based Immunotherapy Revenue Market Share by Players (2019-2024)
3.2 Global Cell-Based Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL-BASED IMMUNOTHERAPY BY REGIONS
4.1 Cell-Based Immunotherapy Market Size by Regions (2019-2024)
4.2 Americas Cell-Based Immunotherapy Market Size Growth (2019-2024)
4.3 APAC Cell-Based Immunotherapy Market Size Growth (2019-2024)
4.4 Europe Cell-Based Immunotherapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Cell-Based Immunotherapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Cell-Based Immunotherapy Market Size by Country (2019-2024)
5.2 Americas Cell-Based Immunotherapy Market Size by Type (2019-2024)
5.3 Americas Cell-Based Immunotherapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell-Based Immunotherapy Market Size by Region (2019-2024)
6.2 APAC Cell-Based Immunotherapy Market Size by Type (2019-2024)
6.3 APAC Cell-Based Immunotherapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell-Based Immunotherapy by Country (2019-2024)
7.2 Europe Cell-Based Immunotherapy Market Size by Type (2019-2024)
7.3 Europe Cell-Based Immunotherapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell-Based Immunotherapy by Region (2019-2024)
8.2 Middle East & Africa Cell-Based Immunotherapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Cell-Based Immunotherapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL-BASED IMMUNOTHERAPY MARKET FORECAST
10.1 Global Cell-Based Immunotherapy Forecast by Regions (2025-2030)
10.1.1 Global Cell-Based Immunotherapy Forecast by Regions (2025-2030)
10.1.2 Americas Cell-Based Immunotherapy Forecast
10.1.3 APAC Cell-Based Immunotherapy Forecast
10.1.4 Europe Cell-Based Immunotherapy Forecast
10.1.5 Middle East & Africa Cell-Based Immunotherapy Forecast
10.2 Americas Cell-Based Immunotherapy Forecast by Country (2025-2030)
10.2.1 United States Cell-Based Immunotherapy Market Forecast
10.2.2 Canada Cell-Based Immunotherapy Market Forecast
10.2.3 Mexico Cell-Based Immunotherapy Market Forecast
10.2.4 Brazil Cell-Based Immunotherapy Market Forecast
10.3 APAC Cell-Based Immunotherapy Forecast by Region (2025-2030)
10.3.1 China Cell-Based Immunotherapy Market Forecast
10.3.2 Japan Cell-Based Immunotherapy Market Forecast
10.3.3 Korea Cell-Based Immunotherapy Market Forecast
10.3.4 Southeast Asia Cell-Based Immunotherapy Market Forecast
10.3.5 India Cell-Based Immunotherapy Market Forecast
10.3.6 Australia Cell-Based Immunotherapy Market Forecast
10.4 Europe Cell-Based Immunotherapy Forecast by Country (2025-2030)
10.4.1 Germany Cell-Based Immunotherapy Market Forecast
10.4.2 France Cell-Based Immunotherapy Market Forecast
10.4.3 UK Cell-Based Immunotherapy Market Forecast
10.4.4 Italy Cell-Based Immunotherapy Market Forecast
10.4.5 Russia Cell-Based Immunotherapy Market Forecast
10.5 Middle East & Africa Cell-Based Immunotherapy Forecast by Region (2025-2030)
10.5.1 Egypt Cell-Based Immunotherapy Market Forecast
10.5.2 South Africa Cell-Based Immunotherapy Market Forecast
10.5.3 Israel Cell-Based Immunotherapy Market Forecast
10.5.4 Turkey Cell-Based Immunotherapy Market Forecast
10.5.5 GCC Countries Cell-Based Immunotherapy Market Forecast
10.6 Global Cell-Based Immunotherapy Forecast by Type (2025-2030)
10.7 Global Cell-Based Immunotherapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Cell-Based Immunotherapy Product Offered
11.1.3 Novartis Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences Cell-Based Immunotherapy Product Offered
11.2.3 Gilead Sciences Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Cell-Based Immunotherapy Product Offered
11.3.3 AbbVie Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Cell-Based Immunotherapy Product Offered
11.4.3 Bristol-Myers Squibb Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Amgen
11.5.1 Amgen Company Information
11.5.2 Amgen Cell-Based Immunotherapy Product Offered
11.5.3 Amgen Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Amgen Main Business Overview
11.5.5 Amgen Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Cell-Based Immunotherapy Product Offered
11.6.3 AstraZeneca Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Biogen
11.7.1 Biogen Company Information
11.7.2 Biogen Cell-Based Immunotherapy Product Offered
11.7.3 Biogen Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Biogen Main Business Overview
11.7.5 Biogen Latest Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Information
11.8.2 Boehringer Ingelheim Cell-Based Immunotherapy Product Offered
11.8.3 Boehringer Ingelheim Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Boehringer Ingelheim Main Business Overview
11.8.5 Boehringer Ingelheim Latest Developments
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Information
11.9.2 Eli Lilly and Company Cell-Based Immunotherapy Product Offered
11.9.3 Eli Lilly and Company Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Eli Lilly and Company Main Business Overview
11.9.5 Eli Lilly and Company Latest Developments
11.10 GSK
11.10.1 GSK Company Information
11.10.2 GSK Cell-Based Immunotherapy Product Offered
11.10.3 GSK Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 GSK Main Business Overview
11.10.5 GSK Latest Developments
11.11 Pfizer
11.11.1 Pfizer Company Information
11.11.2 Pfizer Cell-Based Immunotherapy Product Offered
11.11.3 Pfizer Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Pfizer Main Business Overview
11.11.5 Pfizer Latest Developments
11.12 Roche
11.12.1 Roche Company Information
11.12.2 Roche Cell-Based Immunotherapy Product Offered
11.12.3 Roche Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Roche Main Business Overview
11.12.5 Roche Latest Developments
11.13 Takara Bio
11.13.1 Takara Bio Company Information
11.13.2 Takara Bio Cell-Based Immunotherapy Product Offered
11.13.3 Takara Bio Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Takara Bio Main Business Overview
11.13.5 Takara Bio Latest Developments
11.14 Bausch Health
11.14.1 Bausch Health Company Information
11.14.2 Bausch Health Cell-Based Immunotherapy Product Offered
11.14.3 Bausch Health Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Bausch Health Main Business Overview
11.14.5 Bausch Health Latest Developments
11.15 Apac Biotech
11.15.1 Apac Biotech Company Information
11.15.2 Apac Biotech Cell-Based Immunotherapy Product Offered
11.15.3 Apac Biotech Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Apac Biotech Main Business Overview
11.15.5 Apac Biotech Latest Developments
11.16 Dendreon Pharmaceuticals (SanPower)
11.16.1 Dendreon Pharmaceuticals (SanPower) Company Information
11.16.2 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product Offered
11.16.3 Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Dendreon Pharmaceuticals (SanPower) Main Business Overview
11.16.5 Dendreon Pharmaceuticals (SanPower) Latest Developments
11.17 JW CreaGene
11.17.1 JW CreaGene Company Information
11.17.2 JW CreaGene Cell-Based Immunotherapy Product Offered
11.17.3 JW CreaGene Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 JW CreaGene Main Business Overview
11.17.5 JW CreaGene Latest Developments
11.18 Green Cross Corp
11.18.1 Green Cross Corp Company Information
11.18.2 Green Cross Corp Cell-Based Immunotherapy Product Offered
11.18.3 Green Cross Corp Cell-Based Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Green Cross Corp Main Business Overview
11.18.5 Green Cross Corp Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cell-Based Immunotherapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Autologous Cellular Immunotherapy
Table 3. Major Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Table 4. Major Players of Dendritic Cell-based Vaccine Therapy
Table 5. Cell-Based Immunotherapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Cell-Based Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Cell-Based Immunotherapy Market Size Market Share by Type (2019-2024)
Table 8. Cell-Based Immunotherapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Cell-Based Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Cell-Based Immunotherapy Market Size Market Share by Application (2019-2024)
Table 11. Global Cell-Based Immunotherapy Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Cell-Based Immunotherapy Revenue Market Share by Player (2019-2024)
Table 13. Cell-Based Immunotherapy Key Players Head office and Products Offered
Table 14. Cell-Based Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell-Based Immunotherapy Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Cell-Based Immunotherapy Market Size Market Share by Regions (2019-2024)
Table 19. Global Cell-Based Immunotherapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Cell-Based Immunotherapy Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Cell-Based Immunotherapy Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Cell-Based Immunotherapy Market Size Market Share by Country (2019-2024)
Table 23. Americas Cell-Based Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Cell-Based Immunotherapy Market Size Market Share by Type (2019-2024)
Table 25. Americas Cell-Based Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Cell-Based Immunotherapy Market Size Market Share by Application (2019-2024)
Table 27. APAC Cell-Based Immunotherapy Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Cell-Based Immunotherapy Market Size Market Share by Region (2019-2024)
Table 29. APAC Cell-Based Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Cell-Based Immunotherapy Market Size Market Share by Type (2019-2024)
Table 31. APAC Cell-Based Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Cell-Based Immunotherapy Market Size Market Share by Application (2019-2024)
Table 33. Europe Cell-Based Immunotherapy Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Cell-Based Immunotherapy Market Size Market Share by Country (2019-2024)
Table 35. Europe Cell-Based Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Cell-Based Immunotherapy Market Size Market Share by Type (2019-2024)
Table 37. Europe Cell-Based Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Cell-Based Immunotherapy Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Cell-Based Immunotherapy Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Cell-Based Immunotherapy Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Cell-Based Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Cell-Based Immunotherapy Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Cell-Based Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Cell-Based Immunotherapy Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Cell-Based Immunotherapy
Table 46. Key Market Challenges & Risks of Cell-Based Immunotherapy
Table 47. Key Industry Trends of Cell-Based Immunotherapy
Table 48. Global Cell-Based Immunotherapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Cell-Based Immunotherapy Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Cell-Based Immunotherapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Cell-Based Immunotherapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Novartis Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 53. Novartis Cell-Based Immunotherapy Product Offered
Table 54. Novartis Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Novartis Main Business
Table 56. Novartis Latest Developments
Table 57. Gilead Sciences Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 58. Gilead Sciences Cell-Based Immunotherapy Product Offered
Table 59. Gilead Sciences Main Business
Table 60. Gilead Sciences Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Gilead Sciences Latest Developments
Table 62. AbbVie Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 63. AbbVie Cell-Based Immunotherapy Product Offered
Table 64. AbbVie Main Business
Table 65. AbbVie Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. AbbVie Latest Developments
Table 67. Bristol-Myers Squibb Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 68. Bristol-Myers Squibb Cell-Based Immunotherapy Product Offered
Table 69. Bristol-Myers Squibb Main Business
Table 70. Bristol-Myers Squibb Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Bristol-Myers Squibb Latest Developments
Table 72. Amgen Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 73. Amgen Cell-Based Immunotherapy Product Offered
Table 74. Amgen Main Business
Table 75. Amgen Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Amgen Latest Developments
Table 77. AstraZeneca Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 78. AstraZeneca Cell-Based Immunotherapy Product Offered
Table 79. AstraZeneca Main Business
Table 80. AstraZeneca Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. AstraZeneca Latest Developments
Table 82. Biogen Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 83. Biogen Cell-Based Immunotherapy Product Offered
Table 84. Biogen Main Business
Table 85. Biogen Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Biogen Latest Developments
Table 87. Boehringer Ingelheim Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 88. Boehringer Ingelheim Cell-Based Immunotherapy Product Offered
Table 89. Boehringer Ingelheim Main Business
Table 90. Boehringer Ingelheim Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Boehringer Ingelheim Latest Developments
Table 92. Eli Lilly and Company Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 93. Eli Lilly and Company Cell-Based Immunotherapy Product Offered
Table 94. Eli Lilly and Company Main Business
Table 95. Eli Lilly and Company Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Eli Lilly and Company Latest Developments
Table 97. GSK Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 98. GSK Cell-Based Immunotherapy Product Offered
Table 99. GSK Main Business
Table 100. GSK Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. GSK Latest Developments
Table 102. Pfizer Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 103. Pfizer Cell-Based Immunotherapy Product Offered
Table 104. Pfizer Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Pfizer Main Business
Table 106. Pfizer Latest Developments
Table 107. Roche Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 108. Roche Cell-Based Immunotherapy Product Offered
Table 109. Roche Main Business
Table 110. Roche Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Roche Latest Developments
Table 112. Takara Bio Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 113. Takara Bio Cell-Based Immunotherapy Product Offered
Table 114. Takara Bio Main Business
Table 115. Takara Bio Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Takara Bio Latest Developments
Table 117. Bausch Health Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 118. Bausch Health Cell-Based Immunotherapy Product Offered
Table 119. Bausch Health Main Business
Table 120. Bausch Health Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Bausch Health Latest Developments
Table 122. Apac Biotech Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 123. Apac Biotech Cell-Based Immunotherapy Product Offered
Table 124. Apac Biotech Main Business
Table 125. Apac Biotech Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Apac Biotech Latest Developments
Table 127. Dendreon Pharmaceuticals (SanPower) Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 128. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product Offered
Table 129. Dendreon Pharmaceuticals (SanPower) Main Business
Table 130. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Dendreon Pharmaceuticals (SanPower) Latest Developments
Table 132. JW CreaGene Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 133. JW CreaGene Cell-Based Immunotherapy Product Offered
Table 134. JW CreaGene Main Business
Table 135. JW CreaGene Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. JW CreaGene Latest Developments
Table 137. Green Cross Corp Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 138. Green Cross Corp Cell-Based Immunotherapy Product Offered
Table 139. Green Cross Corp Main Business
Table 140. Green Cross Corp Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Green Cross Corp Latest Developments
Table 1. Cell-Based Immunotherapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Autologous Cellular Immunotherapy
Table 3. Major Players of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Table 4. Major Players of Dendritic Cell-based Vaccine Therapy
Table 5. Cell-Based Immunotherapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Cell-Based Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Cell-Based Immunotherapy Market Size Market Share by Type (2019-2024)
Table 8. Cell-Based Immunotherapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Cell-Based Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Cell-Based Immunotherapy Market Size Market Share by Application (2019-2024)
Table 11. Global Cell-Based Immunotherapy Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Cell-Based Immunotherapy Revenue Market Share by Player (2019-2024)
Table 13. Cell-Based Immunotherapy Key Players Head office and Products Offered
Table 14. Cell-Based Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell-Based Immunotherapy Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Cell-Based Immunotherapy Market Size Market Share by Regions (2019-2024)
Table 19. Global Cell-Based Immunotherapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Cell-Based Immunotherapy Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Cell-Based Immunotherapy Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Cell-Based Immunotherapy Market Size Market Share by Country (2019-2024)
Table 23. Americas Cell-Based Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Cell-Based Immunotherapy Market Size Market Share by Type (2019-2024)
Table 25. Americas Cell-Based Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Cell-Based Immunotherapy Market Size Market Share by Application (2019-2024)
Table 27. APAC Cell-Based Immunotherapy Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Cell-Based Immunotherapy Market Size Market Share by Region (2019-2024)
Table 29. APAC Cell-Based Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Cell-Based Immunotherapy Market Size Market Share by Type (2019-2024)
Table 31. APAC Cell-Based Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Cell-Based Immunotherapy Market Size Market Share by Application (2019-2024)
Table 33. Europe Cell-Based Immunotherapy Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Cell-Based Immunotherapy Market Size Market Share by Country (2019-2024)
Table 35. Europe Cell-Based Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Cell-Based Immunotherapy Market Size Market Share by Type (2019-2024)
Table 37. Europe Cell-Based Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Cell-Based Immunotherapy Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Cell-Based Immunotherapy Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Cell-Based Immunotherapy Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Cell-Based Immunotherapy Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Cell-Based Immunotherapy Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Cell-Based Immunotherapy Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Cell-Based Immunotherapy Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Cell-Based Immunotherapy
Table 46. Key Market Challenges & Risks of Cell-Based Immunotherapy
Table 47. Key Industry Trends of Cell-Based Immunotherapy
Table 48. Global Cell-Based Immunotherapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Cell-Based Immunotherapy Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Cell-Based Immunotherapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Cell-Based Immunotherapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Novartis Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 53. Novartis Cell-Based Immunotherapy Product Offered
Table 54. Novartis Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Novartis Main Business
Table 56. Novartis Latest Developments
Table 57. Gilead Sciences Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 58. Gilead Sciences Cell-Based Immunotherapy Product Offered
Table 59. Gilead Sciences Main Business
Table 60. Gilead Sciences Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Gilead Sciences Latest Developments
Table 62. AbbVie Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 63. AbbVie Cell-Based Immunotherapy Product Offered
Table 64. AbbVie Main Business
Table 65. AbbVie Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. AbbVie Latest Developments
Table 67. Bristol-Myers Squibb Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 68. Bristol-Myers Squibb Cell-Based Immunotherapy Product Offered
Table 69. Bristol-Myers Squibb Main Business
Table 70. Bristol-Myers Squibb Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Bristol-Myers Squibb Latest Developments
Table 72. Amgen Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 73. Amgen Cell-Based Immunotherapy Product Offered
Table 74. Amgen Main Business
Table 75. Amgen Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Amgen Latest Developments
Table 77. AstraZeneca Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 78. AstraZeneca Cell-Based Immunotherapy Product Offered
Table 79. AstraZeneca Main Business
Table 80. AstraZeneca Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. AstraZeneca Latest Developments
Table 82. Biogen Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 83. Biogen Cell-Based Immunotherapy Product Offered
Table 84. Biogen Main Business
Table 85. Biogen Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Biogen Latest Developments
Table 87. Boehringer Ingelheim Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 88. Boehringer Ingelheim Cell-Based Immunotherapy Product Offered
Table 89. Boehringer Ingelheim Main Business
Table 90. Boehringer Ingelheim Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Boehringer Ingelheim Latest Developments
Table 92. Eli Lilly and Company Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 93. Eli Lilly and Company Cell-Based Immunotherapy Product Offered
Table 94. Eli Lilly and Company Main Business
Table 95. Eli Lilly and Company Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Eli Lilly and Company Latest Developments
Table 97. GSK Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 98. GSK Cell-Based Immunotherapy Product Offered
Table 99. GSK Main Business
Table 100. GSK Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. GSK Latest Developments
Table 102. Pfizer Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 103. Pfizer Cell-Based Immunotherapy Product Offered
Table 104. Pfizer Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Pfizer Main Business
Table 106. Pfizer Latest Developments
Table 107. Roche Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 108. Roche Cell-Based Immunotherapy Product Offered
Table 109. Roche Main Business
Table 110. Roche Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Roche Latest Developments
Table 112. Takara Bio Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 113. Takara Bio Cell-Based Immunotherapy Product Offered
Table 114. Takara Bio Main Business
Table 115. Takara Bio Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Takara Bio Latest Developments
Table 117. Bausch Health Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 118. Bausch Health Cell-Based Immunotherapy Product Offered
Table 119. Bausch Health Main Business
Table 120. Bausch Health Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. Bausch Health Latest Developments
Table 122. Apac Biotech Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 123. Apac Biotech Cell-Based Immunotherapy Product Offered
Table 124. Apac Biotech Main Business
Table 125. Apac Biotech Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 126. Apac Biotech Latest Developments
Table 127. Dendreon Pharmaceuticals (SanPower) Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 128. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Product Offered
Table 129. Dendreon Pharmaceuticals (SanPower) Main Business
Table 130. Dendreon Pharmaceuticals (SanPower) Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 131. Dendreon Pharmaceuticals (SanPower) Latest Developments
Table 132. JW CreaGene Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 133. JW CreaGene Cell-Based Immunotherapy Product Offered
Table 134. JW CreaGene Main Business
Table 135. JW CreaGene Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 136. JW CreaGene Latest Developments
Table 137. Green Cross Corp Details, Company Type, Cell-Based Immunotherapy Area Served and Its Competitors
Table 138. Green Cross Corp Cell-Based Immunotherapy Product Offered
Table 139. Green Cross Corp Main Business
Table 140. Green Cross Corp Cell-Based Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 141. Green Cross Corp Latest Developments
LIST OF FIGURES
Figure 1. Cell-Based Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell-Based Immunotherapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Cell-Based Immunotherapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cell-Based Immunotherapy Sales Market Share by Country/Region (2023)
Figure 8. Cell-Based Immunotherapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cell-Based Immunotherapy Market Size Market Share by Type in 2023
Figure 10. Cell-Based Immunotherapy in Hospitals
Figure 11. Global Cell-Based Immunotherapy Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Cell-Based Immunotherapy in Clinics
Figure 13. Global Cell-Based Immunotherapy Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Cell-Based Immunotherapy in Ambulatory Surgical Centers
Figure 15. Global Cell-Based Immunotherapy Market: Ambulatory Surgical Centers (2019-2024) & ($ Millions)
Figure 16. Cell-Based Immunotherapy in Others
Figure 17. Global Cell-Based Immunotherapy Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Cell-Based Immunotherapy Market Size Market Share by Application in 2023
Figure 19. Global Cell-Based Immunotherapy Revenue Market Share by Player in 2023
Figure 20. Global Cell-Based Immunotherapy Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Cell-Based Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 22. APAC Cell-Based Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 23. Europe Cell-Based Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Cell-Based Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 25. Americas Cell-Based Immunotherapy Value Market Share by Country in 2023
Figure 26. United States Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Cell-Based Immunotherapy Market Size Market Share by Region in 2023
Figure 31. APAC Cell-Based Immunotherapy Market Size Market Share by Type in 2023
Figure 32. APAC Cell-Based Immunotherapy Market Size Market Share by Application in 2023
Figure 33. China Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Cell-Based Immunotherapy Market Size Market Share by Country in 2023
Figure 40. Europe Cell-Based Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 41. Europe Cell-Based Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 42. Germany Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Cell-Based Immunotherapy Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Cell-Based Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Cell-Based Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 56. APAC Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 57. Europe Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 59. United States Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 60. Canada Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 63. China Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 64. Japan Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 65. Korea Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 67. India Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 68. Australia Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 69. Germany Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 70. France Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 71. UK Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 72. Italy Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 73. Russia Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 74. Spain Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 77. Israel Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 80. Global Cell-Based Immunotherapy Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Cell-Based Immunotherapy Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Cell-Based Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell-Based Immunotherapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Cell-Based Immunotherapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cell-Based Immunotherapy Sales Market Share by Country/Region (2023)
Figure 8. Cell-Based Immunotherapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cell-Based Immunotherapy Market Size Market Share by Type in 2023
Figure 10. Cell-Based Immunotherapy in Hospitals
Figure 11. Global Cell-Based Immunotherapy Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Cell-Based Immunotherapy in Clinics
Figure 13. Global Cell-Based Immunotherapy Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Cell-Based Immunotherapy in Ambulatory Surgical Centers
Figure 15. Global Cell-Based Immunotherapy Market: Ambulatory Surgical Centers (2019-2024) & ($ Millions)
Figure 16. Cell-Based Immunotherapy in Others
Figure 17. Global Cell-Based Immunotherapy Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Cell-Based Immunotherapy Market Size Market Share by Application in 2023
Figure 19. Global Cell-Based Immunotherapy Revenue Market Share by Player in 2023
Figure 20. Global Cell-Based Immunotherapy Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Cell-Based Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 22. APAC Cell-Based Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 23. Europe Cell-Based Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Cell-Based Immunotherapy Market Size 2019-2024 ($ Millions)
Figure 25. Americas Cell-Based Immunotherapy Value Market Share by Country in 2023
Figure 26. United States Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Cell-Based Immunotherapy Market Size Market Share by Region in 2023
Figure 31. APAC Cell-Based Immunotherapy Market Size Market Share by Type in 2023
Figure 32. APAC Cell-Based Immunotherapy Market Size Market Share by Application in 2023
Figure 33. China Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Cell-Based Immunotherapy Market Size Market Share by Country in 2023
Figure 40. Europe Cell-Based Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 41. Europe Cell-Based Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 42. Germany Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Cell-Based Immunotherapy Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Cell-Based Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Cell-Based Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Cell-Based Immunotherapy Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 56. APAC Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 57. Europe Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 59. United States Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 60. Canada Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 63. China Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 64. Japan Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 65. Korea Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 67. India Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 68. Australia Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 69. Germany Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 70. France Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 71. UK Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 72. Italy Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 73. Russia Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 74. Spain Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 77. Israel Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Cell-Based Immunotherapy Market Size 2025-2030 ($ Millions)
Figure 80. Global Cell-Based Immunotherapy Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Cell-Based Immunotherapy Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Aprepitant Market Growth 2025-2031
US$ 3,660.00
December 2025
86 pages
Global Dental Regenerative Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
81 pages
Global Pelvic Electro-stimulators Market Growth 2024-2030
US$ 3,660.00
February 2024
92 pages
Global Radicut Market Growth 2025-2031
US$ 3,660.00
December 2025
84 pages
